193 related articles for article (PubMed ID: 24069280)
1. Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.
Rubio-Moscardo F; Setó-Salvia N; Pera M; Bosch-Morató M; Plata C; Belbin O; Gené G; Dols-Icardo O; Ingelsson M; Helisalmi S; Soininen H; Hiltunen M; Giedraitis V; Lannfelt L; Frank A; Bullido MJ; Combarros O; Sánchez-Juan P; Boada M; Tárraga L; Pastor P; Pérez-Tur J; Baquero M; Molinuevo JL; Sánchez-Valle R; Fuentes-Prior P; Fortea J; Blesa R; Muñoz FJ; Lleó A; Valverde MA; Clarimón J
PLoS One; 2013; 8(9):e74203. PubMed ID: 24069280
[TBL] [Abstract][Full Text] [Related]
2. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.
Vingtdeux V; Tanis JE; Chandakkar P; Zhao H; Dreses-Werringloer U; Campagne F; Foskett JK; Marambaud P
PLoS One; 2014; 9(11):e112484. PubMed ID: 25386646
[TBL] [Abstract][Full Text] [Related]
3. CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β.
Moreno-Ortega AJ; Buendia I; Mouhid L; Egea J; Lucea S; Ruiz-Nuño A; López MG; Cano-Abad MF
Aging Cell; 2015 Dec; 14(6):1094-102. PubMed ID: 26416646
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
Dreses-Werringloer U; Lambert JC; Vingtdeux V; Zhao H; Vais H; Siebert A; Jain A; Koppel J; Rovelet-Lecrux A; Hannequin D; Pasquier F; Galimberti D; Scarpini E; Mann D; Lendon C; Campion D; Amouyel P; Davies P; Foskett JK; Campagne F; Marambaud P
Cell; 2008 Jun; 133(7):1149-61. PubMed ID: 18585350
[TBL] [Abstract][Full Text] [Related]
5. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
Koppel J; Campagne F; Vingtdeux V; Dreses-Werringloer U; Ewers M; Rujescu D; Hampel H; Gordon ML; Christen E; Chapuis J; Greenwald BS; Davies P; Marambaud P
Mol Med; 2011; 17(9-10):974-9. PubMed ID: 21629967
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1.
Moreno-Ortega AJ; Ruiz-Nuño A; García AG; Cano-Abad MF
Biochem Biophys Res Commun; 2010 Jan; 391(1):722-6. PubMed ID: 19944073
[TBL] [Abstract][Full Text] [Related]
7. CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid.
Giedraitis V; Glaser A; Sarajärvi T; Brundin R; Gunnarsson MD; Schjeide BM; Tanzi RE; Helisalmi S; Pirttilä T; Kilander L; Lannfelt L; Soininen H; Bertram L; Ingelsson M; Hiltunen M
Neurosci Lett; 2010 Jan; 469(2):265-7. PubMed ID: 20005921
[TBL] [Abstract][Full Text] [Related]
8. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.
Lambert JC; Sleegers K; González-Pérez A; Ingelsson M; Beecham GW; Hiltunen M; Combarros O; Bullido MJ; Brouwers N; Bettens K; Berr C; Pasquier F; Richard F; Dekosky ST; Hannequin D; Haines JL; Tognoni G; Fiévet N; Dartigues JF; Tzourio C; Engelborghs S; Arosio B; Coto E; De Deyn P; Del Zompo M; Mateo I; Boada M; Antunez C; Lopez-Arrieta J; Epelbaum J; Schjeide BM; Frank-Garcia A; Giedraitis V; Helisalmi S; Porcellini E; Pilotto A; Forti P; Ferri R; Delepine M; Zelenika D; Lathrop M; Scarpini E; Siciliano G; Solfrizzi V; Sorbi S; Spalletta G; Ravaglia G; Valdivieso F; Vepsäläinen S; Alvarez V; Bosco P; Mancuso M; Panza F; Nacmias B; Bossù P; Hanon O; Piccardi P; Annoni G; Mann D; Marambaud P; Seripa D; Galimberti D; Tanzi RE; Bertram L; Lendon C; Lannfelt L; Licastro F; Campion D; Pericak-Vance MA; Soininen H; Van Broeckhoven C; Alpérovitch A; Ruiz A; Kamboh MI; Amouyel P
J Alzheimers Dis; 2010; 22(1):247-55. PubMed ID: 20847397
[TBL] [Abstract][Full Text] [Related]
9. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
Dreses-Werringloer U; Vingtdeux V; Zhao H; Chandakkar P; Davies P; Marambaud P
J Cell Sci; 2013 Mar; 126(Pt 5):1199-206. PubMed ID: 23345406
[TBL] [Abstract][Full Text] [Related]
10. Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.
Mun MJ; Kim JH; Choi JY; Jang WC
Neurosci Lett; 2016 Apr; 619():8-14. PubMed ID: 26944452
[TBL] [Abstract][Full Text] [Related]
11. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S
J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602
[TBL] [Abstract][Full Text] [Related]
12. CALHM1 polymorphism is not associated with late-onset Alzheimer disease.
Beecham GW; Schnetz-Boutaud N; Haines JL; Pericak-Vance MA
Ann Hum Genet; 2009 May; 73(Pt 3):379-81. PubMed ID: 19472444
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between CALHM1 p.P86L variation and Alzheimer's disease in the Han Chinese population.
Tao QQ; Sun YM; Liu ZJ; Yang P; Li HL; Lu SJ; Wu ZY
Neurobiol Aging; 2014 Aug; 35(8):1956.e13-4. PubMed ID: 24630757
[TBL] [Abstract][Full Text] [Related]
14. CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population.
Cui PJ; Zheng L; Cao L; Wang Y; Deng YL; Wang G; Xu W; Tang HD; Ma JF; Zhang T; Ding JQ; Cheng Q; Chen SD
J Alzheimers Dis; 2010; 19(1):31-5. PubMed ID: 20061624
[TBL] [Abstract][Full Text] [Related]
15. The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts.
Inoue K; Tanaka N; Yamashita F; Sawano Y; Asada T; Goto YI
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):532-535. PubMed ID: 19655363
[TBL] [Abstract][Full Text] [Related]
16. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.
Boada M; Antúnez C; López-Arrieta J; Galán JJ; Morón FJ; Hernández I; Marín J; Martínez-Lage P; Alegret M; Carrasco JM; Moreno C; Real LM; González-Pérez A; Tárraga L; Ruiz A
J Alzheimers Dis; 2010; 20(1):247-51. PubMed ID: 20164592
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Tan K; Peng J; Zhu Y; Wang X
Neurol Sci; 2016 Apr; 37(4):525-32. PubMed ID: 26700797
[TBL] [Abstract][Full Text] [Related]
18. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
[TBL] [Abstract][Full Text] [Related]
19. Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability.
Ma Z; Siebert AP; Cheung KH; Lee RJ; Johnson B; Cohen AS; Vingtdeux V; Marambaud P; Foskett JK
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):E1963-71. PubMed ID: 22711817
[TBL] [Abstract][Full Text] [Related]
20. Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress.
Gallego-Sandín S; Alonso MT; García-Sancho J
Biochem J; 2011 Aug; 437(3):469-75. PubMed ID: 21574960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
